These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30900725)

  • 1. Mechanistic target of rapamycin signaling in mouse models of accelerated aging.
    Lee JY; Kennedy BK; Liao CY
    J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):64-72. PubMed ID: 30900725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOR Signaling Pathway in Cardiac Aging and Heart Failure.
    Daneshgar N; Rabinovitch PS; Dai DF
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication.
    Sahoo BR; Pattnaik A; Annamalai AS; Franco R; Pattnaik AK
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.
    Lamming DW
    Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 27048303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.
    Arriola Apelo SI; Lamming DW
    J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):841-9. PubMed ID: 27208895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mammalian target of rapamycin (mTOR) for health and diseases.
    Tsang CK; Qi H; Liu LF; Zheng XF
    Drug Discov Today; 2007 Feb; 12(3-4):112-24. PubMed ID: 17275731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular effects of the mTOR inhibitor everolimus.
    Saran U; Foti M; Dufour JF
    Clin Sci (Lond); 2015 Nov; 129(10):895-914. PubMed ID: 26330617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2011 Aug; 14(4):437-41. PubMed ID: 21851176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A triple drug combination targeting components of the nutrient-sensing network maximizes longevity.
    Castillo-Quan JI; Tain LS; Kinghorn KJ; Li L; Grönke S; Hinze Y; Blackwell TK; Bjedov I; Partridge L
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20817-20819. PubMed ID: 31570569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Rapamycin a Dietary Restriction Mimetic?
    Unnikrishnan A; Kurup K; Salmon AB; Richardson A
    J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):4-13. PubMed ID: 30854544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation Strategies for Geroprotection via mTORC1 Inhibition.
    Dumas SN; Lamming DW
    J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):14-23. PubMed ID: 30794726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of calorie restriction mimetics to study aging.
    Kitada M; Koya D
    Methods Mol Biol; 2013; 1048():95-107. PubMed ID: 23929100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV.
    Yang JY; Madrakhimov SB; Ahn DH; Chang HS; Jung SJ; Nah SK; Park HY; Park TK
    Cell Commun Signal; 2019 Jun; 17(1):64. PubMed ID: 31200728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Roles of mTOR in ageing and longevity].
    Hara K
    Nihon Rinsho; 2016 Sep; 74(9):1479-1484. PubMed ID: 30557480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
    Gibbons JJ; Abraham RT; Yu K
    Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure.
    Dai DF; Liu Y; Basisty N; Karunadharma P; Dastidar SG; Chiao YA; Chen T; Beyer RP; Chin MT; Maccoss M; La Spada AR; Rabinovitch PS
    Geroscience; 2019 Dec; 41(6):847-860. PubMed ID: 31650481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
    Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
    de Cavanagh EM; Inserra F; Ferder L
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits hydrogen peroxide-induced loss of vascular contractility.
    Gao G; Li JJ; Li Y; Li D; Wang Y; Wang L; Tang XD; Walsh MP; Gui Y; Zheng XL
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1583-94. PubMed ID: 21357511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.